# KOI BIOTHERAPEUTICS INC.: Revolutionizing CAR T-cell Therapy: Enhancing Activity and Persistence of CAR T-cell by Developing a CAR-Enhancer Platform

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | KOI BIOTHERAPEUTICS INC. |
| Location | NEWARK, DE |
| Project | Revolutionizing CAR T-cell Therapy: Enhancing Activity and Persistence of CAR T-cell by Developing a CAR-Enhancer Platform |
| Project number | 5R44CA298774-02 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $703,565 |
| Awarded | 2026-09-03 |
| Project period | 2025-08-12 to 2027-07-31 |
| UEI | QCVXY1DEA743 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11391052). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.